A manager (a member of the Board of Directors, CEO or a member of the Management Team) and persons closely associated with them must notify the Finnish Financial Supervisory Authority of any transactions they conclude with Nightingale's financial instruments without delay and at the latest within two working days of the said transactions (T+2). These notifications must be made by filling out the form that can be downloaded from the Finnish Financial Supervisory Authority’s website and submitted to the Finnish Financial Supervisory Authority in accordance with the instructions set out on the said website.
The relevant manager and persons closely associated with them must also notify the company of any transactions they conclude without delay and at the latest within two working days of the said transactions (T+2). This notification is made by sending the form that must be submitted to the Finnish Financial Supervisory Authority to the company to the following email address: email@example.com.
Nightingale will publish the transaction notifications it receives by publishing a company release without delay and no later than two business days after receipt of notification of the transactions from a manager or a person closely associated with them.
The above mentioned obligations are based on the EU Market Abuse Regulation ((EU) 596/2014).
The notification form and further information can be found here: https://www.finanssivalvonta.fi/en/regulation/regulatory-framework/market-abuse-regulation/managers-transactions/
Information needed on the form:
Nightingale Health Plc’s LEI code: 743700WUIPC24LVMLO66
ISIN codes of Nightingale Health Plc's shares:
- Series B shares: FI4000490875
- Series A shares: FI4000490867
- EMP shares: FI4000490883
Notification reference: Generated automatically (no need to fill in)
Releases related to transactions of managers can be found here.